Literature DB >> 436243

Serum ferritin compared with other indices of iron status in children and teenagers undergoing maintenance hemodialysis.

D Ellis.   

Abstract

To determine how best to assess iron status, I studied 12 young renal patients (ages 5.5 to 20 years) undergoing regular hemodialysis treatments. Iron balance was estimated by monitoring iron loss ascribable to blood loss during dialysis and diagnostic testing, and iron intake in the form of oral and intravenous iron supplements and blood transfusions. Traditional methods of evaluating iron status--measurement of hemoglobin, erythrocyte indices, reticulocyte count, iron, and transferrin--were compared with measurement of serum ferritin. The serum ferritin measurements provided superior information. In three cases this method was superior to visual assessment of bone marrow stained for iron.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 436243

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  4 in total

1.  Treatment of iron overload in children and adolescents on chronic haemodialysis.

Authors:  F J Eijgenraam; R A Donckerwolcke
Journal:  Eur J Pediatr       Date:  1990-02       Impact factor: 3.183

2.  Diagnosis and treatment of iron overload in paediatric patients on chronic haemodialysis.

Authors:  F J Eijgenraam; R A Donckerwolcke; P J van Dijken
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

3.  Assessing iron status in children with chronic renal failure on erythropoietin: which measurements should we use?

Authors:  K P Morris; S Watson; M M Reid; P J Hamilton; M G Coulthard
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

4.  Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis.

Authors:  Raymond D Pratt; Sarah Grimberg; Joshua J Zaritsky; Bradley A Warady
Journal:  Pediatr Nephrol       Date:  2018-07-12       Impact factor: 3.714

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.